Innate Pharma S.A. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ADXN
|
Addex Therapeutics Ltd | $7.26 | $13.74 M | -0.48 | 23 | $1.61 M |
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.52 | $56.28 M | -5.86 | 2 | $0 |
 APM
|
Aptorum Group Limited | $0.73 | $22.80 M | -7.1 | 3 | $431,378 |
 CSBR
|
Champions Oncology, Inc. | $4.55 | $62.53 M | -6.39 | 210 | $50.16 M |
 CYAD
|
Celyad Oncology SA | $0.47 | $14.24 M | -0.32 | 35 | $102,000 |
 CYT
|
Cyteir Therapeutics, Inc. | $3.02 | $108.71 M | -3.25 | 46 | $0 |
 DYAI
|
Dyadic International, Inc. | $1.91 | $59.06 M | -7.21 | 7 | $2.90 M |
 ELYM
|
Eliem Therapeutics, Inc. | $5.11 | $258.33 M | -17.08 | 9 | $0 |
 HCWB
|
HCW Biologics Inc. | $0.77 | $39.35 M | -1.37 | 45 | $2.84 M |
 INBX
|
Inhibrx Biosciences, Inc. | $14.02 | $241.02 M | -1.44 | 166 | $1.80 M |
 IPSC
|
Century Therapeutics, Inc. | $1.20 | $244.54 M | -1.32 | 152 | $2.24 M |
 MNOV
|
MediciNova, Inc. | $2.13 | $67.19 M | -8.06 | 13 | $1.00 M |
 MOLN
|
Molecular Partners AG | $5.29 | $135.05 M | -2.03 | 167 | $7.04 M |
 PRDS
|
Pardes Biosciences, Inc. | $2.18 | $135.19 M | -1.7 | 57 | $0 |
 STTK
|
Shattuck Labs, Inc. | $1.00 | $333.81 M | -3.64 | 75 | $1.66 M |